21 The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina.

22 Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa.

23 TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.

24 The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers

25 Facilitating the Implementation of Virtual Reality-Based Therapies in Pediatric Rehabilitation.

26 Cohort event monitoring of patients treated for uncomplicated malaria with artemisinin-based combination therapies in selected hospitals and community pharmacies in Nigeria.

27 Assessment of the haematological profile of children with malaria parasitaemia treated with three different artemisinin-based combination therapies

28 Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma.

29 Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania

30 Mercuric chloride poisoning: symptoms, analysis, therapies, and autoptic findings. A review of the literature.

31 Implementation of a new health information technology for the management of cancer chemotherapies.

32 The role of music therapy and alternative therapies in the treatment of ADHD: An exploratory study

33 Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.

34 Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis.

35 Common Data Elements for Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Working Group on Hospital Course and Acute Therapies—Proposal of a Multidisciplinary Research Group

36 [Treatment of hand-foot syndrome in the context of targeted therapies].

37 A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies.

38 Zum Einsatz von Informationstechnologie zur Verbesserung der Arzneimitteltherapiesicherheit (Memorandum AMTS-IT)

39 Endovascular Therapy for Vasculogenic Erectile Dysfunction: A Systematic Review and Meta-Analysis of Arterial and Venous Therapies

40 Comparison of the efficacy of 308-nm excimer lamp monotherapy with topical tacrolimus or clobetasol 17-propionate combination therapies in localized vitiligo

41 Nuclear Receptors: Recent Drug Discovery for Cancer Therapies

42 Zuständigkeit und Zulässigkeit der Feststellungsklage bei Klagen der Arzneimittelhersteller gegen die Arzneimittelrichtlinie. Keine Freistellung von Verordnungseinschränkungen oder -ausschlüssen bei Arzneimitteln der besonderen Therapierichtungen

43 Current and emerging therapies in premature ejaculation: Where we are coming from, where we are going.

44 ULTRASOUND MONITORING IN THE EVALUATION OF THE FUNCTIONAL STATE OF A KIDNEY TRANSPLANT AT DIFFERENT IMMUNOSUPPRESSION THERAPIES

45 Attitudes Towards the Use of Routine Outcome Monitoring of Psychological Therapies Among Mental Health Providers: The EBPAS-ROM.

46 Effect of acupoint therapies on chemotherapy-induced nausea and vomiting: A systematic review protocol.

47 YouTube videos on oral systemic therapies for psoriasis: a cross-sectional analysis

48 Using distance technology to deliver the creative arts therapies to veterans: Case studies in art, dance/movement and music therapy

49 Improving motivation in wrist rehabilitation therapies

50 State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies.

51 Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement.

52 Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review.

53 Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C.

54 Transgenic Tumor Models for Evaluating CAR T-Cell Immunotherapies.

55 A systematic review and network meta-analysis of existing pharmacologic therapies in patients with idiopathic sudden sensorineural hearing loss.

56 Aphasia and reperfusion therapies in hyper-acute settings: A scoping review.

57 Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.

58 The Current Status of Cell-Based Therapies for Primary Knee Osteoarthritis.

59 Innovations in Oral Therapies for Inflammatory Bowel Disease.

60 Focused Ultrasonography-Mediated Blood-Brain Barrier Disruption in the Enhancement of Delivery of Brain Tumor Therapies

61 Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

62 The effect of electrical stimulation therapies on spinal fusion: a cross-disciplinary systematic review and meta-analysis of the preclinical and clinical data.

63 Emerging CAR T cells therapies: clinical landscape and patent technological routes.

64 What Should We Expect from Future Therapies for Inflammatory Bowel Disease?

65 Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease

66 Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host–pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis

67 Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies

68 Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience.

69 The NeST (neoadjuvant systemic therapy in breast cancer) study - Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer.

70 Turkish-speaking service-user experience of guided self-help in an improving access to psychological therapies service: Using discovery interviews to improve services

71 Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori

72 Human Adipose Tissue Derivatives as a Potent Native Biomaterial for Tissue Regenerative Therapies.

73 An update on pharmacotherapies in diabetic dyslipidemia

74 Gold Nanoshell-Linear Tetrapyrrole Conjugates for Near Infrared-Activated Dual Photodynamic and Photothermal Therapies.

75 Intracellular RNA Sensing in Mammalian Cells: Role in Stress Response and Cancer Therapies.

76 Use of Complementary and Integrative Therapies by Fibromyalgia Patients: A 14-Year Follow-up Study.

77 Comparison of the effects of islamic spiritual educations and breathing techniques with heart rate variability feedback therapies on heart rate variability, psychophysiological coordination and stress in patients undergoing coronary artery bypass graft surgery

78 Barriers to the registration and conduct of Cochrane systematic reviews of traditional East Asian medicine therapies.

79 Optimizing and normalizing the population through hormone therapies in Italian science, 1926-1950.

80 How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?

81 An exploration of how working in the Improving Access to Psychological Therapies (IAPT) programme might affect the personal and professional development of counsellors: an analytical autoethnographic study

82 Scientometrics on interventions used for adherence of hypertension and diabetes therapies.

83 Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

84 Intratympanic Therapies in Ménière Disease: Evaluation of Outcomes and Early Vertigo Control.

85 TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.

86 Genetic therapies, human genetic enhancement, and … eugenics?

87 A Current Review of the Children and Young People's Improving Access to Psychological Therapies (CYP IAPT) Program: Perspectives on Developing an Accessible Workforce.

88 Integration of global analyses of host molecular responses with clinical data to evaluate pathogenesis and advance therapies for emerging and re-emerging viral infections

89 Die Wirksamkeit der Radiofrequenztherapie mit isolierten Mikronadeln zur Reduktion von hervortretenden infraorbitalen Fettpolstern.

90 Wirksamkeit einer ablationsbasierten Kombinationstherapie bei Vitiligo: Eine systematische Übersichtsarbeit und Metaanalyse.

91 ARZNEIMITTEL UND THERAPIE: Zweifel an Wirksamkeit von Zink

92 Anticholinerge Therapie der OAB

93 Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic.

94 Reply to "COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution".

95 SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.

96 Global mapping of interventions to improve quality of life using mind-body therapies during 1990-2018.

97 EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.

98 Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration: The Pulsing Heart of Advanced Therapies.

99 Dropout from psychological therapies for post-traumatic stress disorder (PTSD) in adults: systematic review and meta-analysis

100 COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”

101 COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies.

Keyword Connections

Journals

Research Groups

Bibliographies